Melatonin in cardiac ischemia/reperfusion-induced mitochondrial adaptive changes

Area of Science:

• Biochemistry
• Cardiology
• Mitochondrial Physiology

Background:

• Melatonin, an indoleamine, rapidly distributes to all cell compartments, with high concentrations in mitochondria.
• Cytochrome c (cyt c) is a melatonin target, undergoing oxidation by melatonin in the presence of hydrogen peroxide.
• Melatonin's antioxidant properties are known to protect against cardiac ischemia/reperfusion (I/R)-induced mitochondrial oxidative damage by modulating reactive oxygen species (ROS).

Purpose of the Study:

• To investigate the role of melatonin in the context of cardiac ischemia/reperfusion (I/R) injury, particularly concerning mitochondrial adaptation and cytochrome c (cyt c) function.
• To evaluate the potential benefits or detriments of melatonin treatment during cardiac I/R, considering its interaction with cyt c and nitric oxide (NO)-mediated pathways.

Main Methods:

• Analysis of melatonin's interaction with mitochondrial cytochrome c (cyt c) and its oxidation mechanism.
• Examination of mitochondrial response to ischemia and hypoxia, focusing on cytochrome c oxidase (COX) adaptation to oxygen availability.
• Investigation of the role of nitric oxide (NO) in COX inhibition during ischemia and its impact on ROS generation.
• Evaluation of melatonin's effect on cyt c up-regulation in the context of reperfusion injury.

Main Results:

• Severe ischemia/hypoxia induces mitochondrial adaptation via NO-mediated COX inhibition, limiting ROS generation during ischemia.
• Melatonin's potential to up-regulate cyt c could be detrimental during cardiac ischemia by interfering with this adaptive mechanism.
• Reperfusion following ischemia causes a significant ROS surge due to a mismatch between restored oxygen and down-regulated COX activity.
• Melatonin, by up-regulating cyt c, may counteract the ROS overproduction associated with the "reperfusion syndrome" and myocardial stunning.

Conclusions:

• Melatonin's role in cardiac ischemia/reperfusion (I/R) is complex; while protective as an antioxidant, its potential to up-regulate cytochrome c (cyt c) could be harmful during ischemia.
• During reperfusion, melatonin's cyt c up-regulating effect may be beneficial in mitigating ROS generation and the associated "reperfusion syndrome."
• Further research is needed to clarify melatonin's therapeutic window and precise role in managing cardiac I/R injury.